Compare GPC & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPC | SNN |
|---|---|---|
| Founded | 1928 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 14.3B |
| IPO Year | 1994 | N/A |
| Metric | GPC | SNN |
|---|---|---|
| Price | $115.38 | $36.62 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | ★ $145.67 | $32.83 |
| AVG Volume (30 Days) | ★ 1.4M | 724.6K |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.64% | 2.00% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $24,300,141,000.00 | N/A |
| Revenue This Year | $4.89 | $7.68 |
| Revenue Next Year | $4.57 | $5.47 |
| P/E Ratio | $248.70 | ★ $64.97 |
| Revenue Growth | ★ 3.46 | N/A |
| 52 Week Low | $104.01 | $23.91 |
| 52 Week High | $151.57 | $38.79 |
| Indicator | GPC | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 29.34 | 64.11 |
| Support Level | N/A | $36.53 |
| Resistance Level | $129.07 | $37.26 |
| Average True Range (ATR) | 3.66 | 0.46 |
| MACD | -2.79 | 0.06 |
| Stochastic Oscillator | 2.71 | 92.89 |
Genuine Parts sells aftermarket automotive parts (60% of sales) and industrial products (40% of sales) in the United States and internationally. The automotive segment primarily acts as a distributor to its network of 9,800 global retail locations, of which about two-thirds are independently owned and operated. We estimate Genuine serves around 6,000 retail locations in the US operating under the Napa Auto Parts brand, with about 80% of end-market sales derived from professional customers. Its industrial segment, primarily operating under the Motion name in the United States, is a leading distributor of bearings, power transmission, and other industrial products to more than 200,000 maintenance, repair, and original equipment manufacturer customers.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.